Date Time | Announcment |
|---|---|
| Sep 12, 2026, 4:15 PM IST | Vista Pharmaceutical - Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer |
| Aug 14, 2026, 9:06 PM IST | Vista Pharmaceutical - Board Meeting Outcome for Results For The Quarter Ended 30.06.2026 |
| Aug 14, 2026, 9:00 PM IST | Vista Pharmaceutical - Results For The Quarter Ended 30.06.2026 |
| Aug 13, 2026, 4:11 PM IST | Vista Pharmaceutical - Board Meeting Intimation for Approval Of Un Audited Financials Results For The Quarter Ended 30.06.202 |
| Jul 15, 2026, 10:52 PM IST | Vista Pharmaceutical - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 |
| May 29, 2026, 8:47 PM IST | Vista Pharmaceutical - Outcome Of Board Meeting Under Regulations 30 Read With 33 (3) Of SEBI (Listing Obligations And Disclo |
| May 19, 2026, 10:13 PM IST | Vista Pharmaceutical - Board Meeting Intimation for Approval Of Audited Financial Results For The Quarter And Year Ended 31.0 |
| Apr 29, 2026, 5:30 AM IST | Vista Pharmaceutical - Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2 |
| Apr 14, 2026, 10:32 PM IST | Vista Pharmaceutical - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 |
| Feb 13, 2026, 8:56 PM IST | Vista Pharmaceutical - Board Meeting Outcome for Un Audited Financial Results For The Quarter Ended 31.12.2025 |